Summary
Prokinetic agents might be useful in patients with progressive systemic sclerosis (PSS) who have disturbed function of the lower esophageal sphincter and impaired acid-clearance of the tubular esophagus. We therefore compared, by means of esophageal manometry, the effect of 20 mg cisapride orally vs. placebo in 12 patients with progressive systemic sclerosis and proven esophageal dysfunction as well as in 10 healthy volunteers in a double-blind, prospective trial. An increase of the lower esophageal resting pressure from 18.1±2.4 mm Hg to 23.9±8.1 mm Hg* after cisapride administration was observed in healthy volunteers, and from 10.9±3.2 mm Hg to 13.6+4.0 mm Hg* in the PSS patients. The amplitudes of peristaltic waves in the distal part of the esophagus were increased by cisapride from 83.8±10.6 mm Hg to 95.6±15.5mm Hg* in volunteers and from 28.9+12.8 mm Hg to 36.8±16.2 mm Hg in patients (*:P<0.05). These results indicate that cisapride has a therapeutic rationale in the treatment of esophageal dysfunction in PSS; further clinical investigations are justified.
Similar content being viewed by others
Abbreviations
- PSS:
-
progressiv systemische Sklerodermie
- UÖS:
-
unterer Oesophagussphinkter
- OÖS:
-
oberer Oesophagussphinkter
- ¯x:
-
Mittelwert
- SD:
-
Standardabweichung
- n.s.:
-
nicht signifikant
- p.o.:
-
per os
- vs.:
-
versus
- i.v.:
-
intravenös
- pH:
-
Wasserstoffionenkonzentration
- H2 :
-
Histamin-Rezeptoren Typ 2
Literatur
Barry JZ, Hirschberg J, Ippoliti AF, Furst DE, Clements PJ, Weinstein WM (1987) Esophagitis in scleroderma. Gastroenterology 92:421–428
Castell JA, Castell DO (1986) Computer analysis of human esophageal peristalsis and lower esophageal sphincter pressure. Dig Dis Sci 31:1211–1216
Ceccatelli P, Janssens J, Vantrappen G, Cuchiara S (1988) Cisapride restores the decreased lower oesophageal sphincter pressure in reflux patients. Gut 29:631–635
Collins BJ, Lowe AHG (1986) The effect of chronic administration of cisapride on the 16 hour profile, oesophageal transit and gastric emptying of patients with evidence of gastro-oesophageal reflux: a placebo controlled trial. Digestion 34:142
Dent J, Dodds WJ, Sekiguchi T, Hogan WJ, Arndorfer RC (1983) Interdigestive phasic contractions of the human lower esophageal sphincter. Gastroenterology 84:453–460
Feussner H, Kreis M, Weiser HF (1988) Motilitätsstörungen des Oesophagus bei progressiver systemischer Sklerodermie. Hautarzt 39:291–297
Gilbert RJ, Dodds WJ, Kahrilas PJ, Hogan WJ, Lipman S (1987) Effect of cisapride, a new prokinetic agent, on esophageal motor function. Dig Dis Sci 32:1331–1336
Horowitz M, Maddern GJ, Maddox A, Wishart J, Chatterton BE, Shearman DJC (1987) Effects of cisapride on gastric and esophageal emptying in progressive systemic sclerosis. Gastroenterology 93:311–315
Kahrilas PJ, Dodds WJ, Hogan WJ (1988) Effect of peristaltic dysfunction on esophageal volume clearance. Gastroenterology 94:73–80
Krejs GJ, Lobsinger MM (1974) Oesophagusfunktion bei Sklerodermie. Acta hepato-gastroenterol 44:236–240
McCallum RW, Chakrapani P, Campoli-Richards DM, Goa KL (1988) Cisapride, Drugs 36:652–681
Sachs L (1987) Angewandte Statistik. 7. Aufl., Springer, Berlin Heidelberg New York
Schuurkes JAJ, Van Nueten JM, Van Daele PGH, Reyntjens AJ, Janssen PAJ (1985) Motor stimulating properties of cisapride on isolated gastrointestinal preparations of the guinea pig. J Pharm Exp Ther 234:775–783
Stentoft P, Hendel L, Aggestrup S (1987) Esophageal manometry and pH-probe monitoring in the evaluation of gastroesophageal reflux in patients with progressive systemic sclerosis. Scand J Gastroenterol 22:499–504
Weihrauch TR, Korting GW (1983) Manometric assessment of esophageal involvement in progressive systemic sclerosis, morphea and Raynaud's disease. Ann Int Med 59:433–443
Wienbeck M, Cuder-Wiesinger E, Berges W (1988) Cisapride acts as a motor stimulator in the human esophagus. Gastroenterology 86:1298
Weiser HF, Hölscher A, Zimmermann T (1986) Effect of cisapride and metoclopramide on the lower oesophageal motility. A pressure and ph-metric study. Digestion 34:146
Author information
Authors and Affiliations
Additional information
Die Untersuchung erfolgte mit finanzieller Unterstützung der Janssen GmbH, Neuss.
Rights and permissions
About this article
Cite this article
Wehrmann, T., Caspary, W.F. Einfluß von Cisaprid auf die Oesophagusmotilität bei Gesunden und Patienten mit progressiver systemischer Sklerodermie. Klin Wochenschr 68, 602–607 (1990). https://doi.org/10.1007/BF01660958
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01660958